The semaglutide segment dominated the market with a major share of 46% in 2025 because of its robust clinical efficacy in glycemic control and weight loss, which is backed by a wealth of empirical data
Lipid peroxidation, a principal feature of ferroptosis, generates products such as MDA, 4-hydroxyhexenal, and 4-HNE that serve as valuable indicators for assessing the extent of lipid peroxidation and ferroptosis (14, 56)
Auris Nasus Larynx 49(6):905911
Cycling on and off GLP-1s (stopping treatment with planned restart) The Approach Cycling on and off GLP-1s means taking a planned break from treatment for a defined period, then re-starting on a schedule agreed in advance
Risk and Handling Precautions Risk Tier: MODERATE This rating reflects both peptides' bioactive activity at angiogenic and cytoskeletal signaling pathways in preclinical models, the absence of established human safety profiles for either compound, and the additional handling considerations specific to intranasal formulations
Public summary of positive opinion for orphan designation of mescasermin for the treatment of primary insulin-like growth factor-1 deficiency due to molecular or genetic defects